<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="of safe and efficacious mucosal vaccines that mimic the natural" exact="infection" post="route and cut off the AIVs infection route. Here,"/>
 <result pre="mimic the natural infection route and cut off the AIVs" exact="infection" post="route. Here, we discussed the current status and advancement"/>
 <result pre="review will help to not only understand and predict AIVs" exact="infection" post="characteristics in birds but also extrapolate them for distinction"/>
 <result pre="evoke a better local immune response [17]. Given that the" exact="infection" post="and spread of AIVs occur at mucosal surfaces, vaccine"/>
 <result pre="adopt more adequate vaccine strategies for the control of AIVs" exact="infection" post="and epidemics. 2. Host Immune Responses to Influenza Viruses"/>
 <result pre="constitutes the first line of protection from invading pathogens. AIV" exact="infection" post="results in a recognition of viral conserved components called"/>
 <result pre="in mammals [28]. The roles of NLR signaling in bacterial" exact="infection" post="have been broadly investigated [29]. IAV infection activates NLR"/>
 <result pre="signaling in bacterial infection have been broadly investigated [29]. IAV" exact="infection" post="activates NLR family pyrin domain containing 3 (NLRP3) and"/>
 <result pre="signaling is involved in the protective adaptive responses to IAV" exact="infection" post="[33]. Conversely, other studies demonstrated that the NLRP3 signaling"/>
 <result pre="In the case of the humoral immune response, influenza virus" exact="infection" post="leads to production of antibodies (Abs) against the viral"/>
 <result pre="T cells play a role in controlling the secondary influenza" exact="infection" post="that is independent of CD8+ T cells or B"/>
 <result pre="The mucosal immune system plays a crucial role in controlling" exact="infection" post="with influenza viruses in the URT (Figure 2). The"/>
 <result pre="immune system in the host responds to the initial IAV" exact="infection" post="by producing antiviral and immunomodulatory components, including mucins, lectins,"/>
 <result pre="immunoglobulins [58]. The entry of IAVs into epithelial cells renders" exact="detection" post="of the viral PAMPs by the local immune cells"/>
 <result pre="to IgG, IgA exerts a key role in preventing from" exact="infection" post="of the human URT mucosa with influenza viruses [60],"/>
 <result pre="A/Yamagata/120/86) HA immunization can lead to protection of mice against" exact="infection" post="with multiple virus strains [62,63]. In this case, while"/>
 <result pre="a decline in the efficiency of protection against heterologous virus" exact="infection" post="[64]. It has been demonstrated that S-IgA purified from"/>
 <result pre="efficient, valuable, and low-cost means for effectively controlling the virus" exact="infection" post="and subsequently reducing morbidity and mortality. However, all these"/>
 <result pre="to elicit local mucosal immunity on the location of initial" exact="infection" post="[73], representing a limited capacity of the conventional vaccines"/>
 <result pre="the mucosal surface have the capacity to effectively prevent virus" exact="infection" post="due to the fact that these Abs remain active"/>
 <result pre="nasal wash or serum, which protect mice against variant virus" exact="infection" post="[77]. Okamoto et al. found that intranasal formalin-inactivated whole-virion"/>
 <result pre="the viruses and identify the molecular pathogenesis related to influenza" exact="infection" post="and the working mechanism underlying normal mucosal immunization. 4."/>
 <result pre="viruses. In recent years, research on the prevention of influenza" exact="infection" post="by nasal immunity has gained more and more attention."/>
 <result pre="important feature of LAIVs is that they elicit a minor" exact="infection" post="at the site of challenge and present a high"/>
 <result pre="an advantage in inducing local immunity at the site of" exact="infection" post="to systemic vaccination. However, mucosal surfaces display a broad"/>
 <result pre="to conventional influenza vaccines [117]. In the past two years," exact="testing" post="of DNA vaccination for targeting the mucosa has revealed"/>
 <result pre="high levels of Abs against HI and protect chickens from" exact="infection" post="with H7N9 or HPAI H5N1 virus, indicative of the"/>
 <result pre="intranasal administration of LAIVs can effectively protect from the seasonal" exact="infection" post="and even induces cross-protective immune response against drifted strains"/>
 <result pre="of AIVs is accelerating, thereby increasing the risk of human" exact="infection" post="and harm to the economy and society. Therefore, speeding"/>
 <result pre="highly pathogenic H7N9 avian influenza virus in ChinaJ. Infect.201775717510.1016/j.jinf.2017.04.00128390707 8.YuanR.LiangL.WuJ.KangY.SongY.ZouL.ZhangX.NiH.KeC.Human" exact="infection" post="with an avian influenza A/H9N2 virus in Guangdong in"/>
 <result pre="Infect. Dis.201765310.1093/cid/cix334 11.LaiS.YingQ.CowlingB.J.XiangR.WardropN.A.GilbertM.TsangT.K.PengW.FengL.HuiJ.Global epidemiology of avian influenza A H5N1 virus" exact="infection" post="in humans, 1997â€&quot;2015: A systematic review of individual case"/>
 <result pre="and subversion of pattern-recognition receptor signallingNat. Rev. Immunol.2008891192210.1038/nri243618989317 26.YoneyamaM.OnomotoK.JogiM.AkaboshiT.FujitaT.Viral RNA" exact="detection" post="by RIG-I-like receptorsCurr. Opin. Immunol.201532485310.1016/j.coi.2014.12.01225594890 27.HiscottJ.LinR.NakhaeiP.PazS.MasterCARD: A priceless link"/>
 <result pre="of caspase-1Immunity20093056657510.1016/j.immuni.2009.02.00619362023 36.KrammerF.The human antibody response to influenza A virus" exact="infection" post="and vaccinationNat. Rev. Immunol.20191938339710.1038/s41577-019-0143-630837674 37.Van de SandtC.E.KreijtzJ.H.RimmelzwaanG.F.Evasion of influenza"/>
 <result pre="effects of specific immunity to viral neuraminidase on influenza virus" exact="infection" post="of miceJ. Virol.1968277878610.1128/JVI.2.8.778-786.19685701819 39.LaMereM.W.LamH.T.MoquinA.HaynesL.LundF.E.RandallT.D.KaminskiD.A.Contributions of antinucleoprotein IgG to heterosubtypic"/>
 <result pre="Activation by Antibodies to Internal Influenza Virus ProteinsEBioMedicine2016827729010.1016/j.ebiom.2016.04.02927428437 41.IngulliE.MondinoA.KhorutsA.JenkinsM.K.In vivo" exact="detection" post="of dendritic cell antigen presentation to CD4(+) T cellsJ."/>
 <result pre="and memory at mucosal surfacesVaccine20072554675484410.1016/j.vaccine.2006.12.00117227687 62.TamuraS.FunatoH.HirabayashiY.SuzukiY.NagamineT.AizawaC.KurataT.Cross-protection against influenza A virus" exact="infection" post="by passively transferred respiratory tract IgA antibodies to different"/>
 <result pre="influenza epidemicsExpert. Rev. Vaccines20181768769610.1080/14760584.2018.150774330092690 64.Asahi-OzakiY.YoshikawaT.IwakuraY.SuzukiY.TamuraS.KurataT.SataT.Secretory IgA antibodies provide cross-protection against" exact="infection" post="with different strains of influenza B virusJ. Med. Virol.20047432833510.1002/jmv.2017315332283"/>
 <result pre="infectionMicrobes. Infect.20161838739810.1016/j.micinf.2016.03.00827005450 75.TamuraS.TanimotoT.KurataT.Mechanisms of broad cross-protection provided by influenza virus" exact="infection" post="and their application to vaccinesJpn. J. Infect. Dis.20055819520716116250 76.HasegawaH.IchinoheT.AinaiA.TamuraS.KurataT.Development"/>
 <result pre="administration of inactivated influenza virus vaccineJ. Infect. Dis.199717535236310.1093/infdis/175.2.3529203656 102.St PaulM.MallickA.I.ReadL.R.VillanuevaA.I.ParviziP.Abdul-CareemM.F.NagyE.SharifS.Prophylactic" exact="treatment" post="with Toll-like receptor ligands enhances host immunity to avian"/>
 <result pre="virus in chickensVaccine2012304524453110.1016/j.vaccine.2012.04.03322531557 103.ScheepersK.BechtH.Protection of mice against an influenza virus" exact="infection" post="by oral vaccination with viral nucleoprotein incorporated into immunostimulating"/>
 <result pre="novel nasal ODN adjuvant elicits complete protection from influenza virus" exact="infection" post="without causing inflammatory immune responsesVaccine2019375382538910.1016/j.vaccine.2019.07.03231345642 108.KangH.WangH.YuQ.YangQ.A novel combined adjuvant"/>
</results>
